Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3955_Библиотеки_им_академика_М_И_Перельмана.pdf
Index 345
RAS, see Renal artery stenosis (RAS)
Renal angiogram, 145f
Renal artery angioplasty/stenting
alternative therapies, 150
clinical features, 141
complications and their treatment, 150–151
contraindications, 143
diagnostic evaluation
imaging, 142–143
laboratory, 141
equipment, 144
follow-up and post-procedure medications,
149
immediate post-procedure care, 149
laboratory, 143
patient preparation, 144
performing the procedure
angioplasty/deploying stent, 148–149
crossing lesion, 147
pre-procedure medications, 145
procedure
access, 145
angiography, 146
assessing the lesion, 146–147
intra-procedural medications, 147
relevant anatomy
aberrant anatomy, 144
normal anatomy, 144
results of RAS, 150
Renal artery dissection, 151
Renal artery rupture, 151
Renal artery spasm, 151
Renal artery stenosis (RAS), 141, 146
Renal artey stent placement, spasm caused by
wire after, 148f
Renal atheroembolism, 151
Restenosis, 70
Retrograde common femoral artery (CFA),
29–30
Right internal jugular vein (RIJV)
longitudinal image, 50f
transverse image, 48f
variations in, 49f
transverse ultrasound image of needle
puncture, 51f
ultrasound-guided puncture, 50f
Ruptured abdominal aortic aneurysms
(rAAAs), 239
S
Saad, Nael E. A., 317
SAFARI technique, 136
Sapoval, Marc, 129
Schoder, Maria, 225
Secondary stenting, 67
Seldinger technique, 42, 145
Seriki, Dare M., 73
SFA, see Superficial femoral artery (SFA)
SFA occlusion in calcified artery, 106f
Shah, Himanshu, 251
Sharma, Jitendra, 187
Sheaths and guide catheters, 2–3
Siddiqui, Adnan H., 187
Smith, Tony P., 291
Smoking, managing before medications, 17
Soong, Chee Voon, 225
Stand-alone percutaneous mechanical
thrombectomy(PMT), 323–324
StarClose, 78
Stenosed aortomesenteric venous bypass graft,
162f
Stenotic lesion, renal artery rupture during
balloon angioplasty, 64f
Stent-assisted angioplasty
angioplasty versus, 191
Stent grafts, 11, 67, 242
AUI two-part system, 242f
Stenting
alternative, therapies, see Therapies,
alternative
principles, see Principles of angioplasty
and stenting
secondary, 67
tools, see Tools to perform angioplasty and
stenting
venoplasty and, see Venoplasty and
stenting
Stents, 8–11, 67, 135
properties, 10t
Streptokinase, 23
Stroke, 222
CT evaluation of, 294f
syndromes, 293t
Subclavian and axillary arteries, angio-
plasty/stenting of
alternative therapies, 205
clinical features, 195
complications, 205–206
contraindications, 197
diagnostic evaluation
clinical assessment, 196
imaging, 196–197
laboratory investigations, 196
equipment specific to this scenario, 200
follow-up and post-procedure medications,
204–205
346 Index
indications for treatment, 197
patient preparation, 197–198
pre-procedure medications, 200
procedure
angiography, 201
arterial access, 201
assessing the lesion, 202–203
immediate post-procedural care, 204
intra-procedural medications, 201
performing the procedure, 203–204
relevant anatomy
aberrant anatomy, 199
normal anatomy, 198
results, 205
Subclavian vein, venous access, into, 51
anatomy, 52
complications, 53
contraindications, 52
indications, 52
patient preparation, 52
performing the procedure
using anatomical landmarks, 52
using fluoroscopic guidance, 53
using ultrasound guidance, 53
Subintimal angioplasty, 66–67
alternative therapies, 126
for below knee occlusions, 121–122
clinical features, 111
complications
distal embolization, 126
vessel perforation, 126–127
confirm creation of dissection, 118f
contraindications, 113
diagnostic evaluation, 111
clinical, 111–112
imaging, 112–113
laboratory, 112
follow-up and post-procedure care, 124
in iliac artery occlusions, 122
indications, 113
patent, spiraling post-angioplasty channel,
123f
patient preparation, 113–114
popliteal segment excluded by new
dissection, 125f
pre-procedure medication, 115
procedure
access, 115
angiography, 115
assessing lesion, 116
immediate post-procedure care, 124
intra-procedural medication, 116
performing the procedure, 116–124
puncture of, 117f
relevant anatomy, 114
results, 124–125
specific equipment, 114–115
of superficial femoral artery (SFA), 68f
wire supported by balloon catheter, 119f
Subintimal recanalization, 137f
Superficial femoral artery (SFA), 30
antegrade approach for, 116–119
re-entry, 119–120
re-entry catheters, 120
subintimal angioplasty of, 30, 68f
Superficial femoral artery and popliteal artery,
angioplasty/stenting of
alternative therapies, 108
clinical features, 97
complications, 108–109
contraindications, 98
diagnostic evaluation
clinical, 97
imaging, 98
laboratory, 98
equipment, 101
indications, 98
patient preparation, 99–100
preprocedure medications, 101–102
procedure
angiography, 102
arterial access, 102
assessing lesion, 103–104
follow-up and post-procedure care, 107
immediate post-procedure care, 107
intra-procedural medications, 103
performing the procedure, 104–107
relevant anatomy
aberrant anatomy, 100
normal anatomy, 100
results, 107–108
Superior mesenteric artery (SMA), 153, 226,
241
SVC syndrome (SVCS), 303–304
Synovial cancer requiring right pneumonec-
tomy, 307f
Systemic revascularization syndrome, 279
Syvec patch, 80
T
TASC classification
of aorto-iliac lesions, 92f
of femoral and popliteal lesions, 99f
TEVR, see Thoracic endovascular repair
(TEVR)
Index 347
Therapies, alternative
aortoiliac angioplasty and stenting, 87–88
aortoiliac occlusive disease, 87–88
carotid stenting/angioplasty, 183
endovascular management of ruptured
abdominal aortic aneurysm, 248
endovascular treatment of aortoiliac
occlusive disease, 87–88
hemodialysis access, angio-
plasty/stenting/lysis/thrombectomy
of, 272
infrapopliteal angioplasty and stenting, 139
mesenteric arteries, angioplasty/stenting of,
162
renal artery angioplasty and stenting, 150
subclavian and axillary arteries,
angioplasty/stenting of, 205
subintimal angioplasty, 126
superficial femoral artery and popliteal
artery, angioplasty and stenting of,
108
venoplasty and stenting, 313–314
Thoracic aorta, stent-grafting of
clinical features, 207
types of pathology treated by TEVR,
207
complications
general complications, 222
related to vascular access, 222
stent related, 221–222
contraindications, 211
diagnostic evaluation
clinical, 207–208
laboratory, 208
pre-interventional imaging, 208–210
equipment
endografts, 213–215
other equipment required for TEVR,
215
follow-up and post-procedure medications,
220
indications
elective indications, 211
extended indications, 211
urgent indications, 211
patient preparation, 212
pre-procedure medications, 215
procedure
angiography, 216
arterial access, 215–216
deploying the endograft, 217
endpoint, 217–218
immediate post-procedural care,
218–219
intra-procedural medications, 217
relevant anatomy, 212–213
results, 220
aneurysms, 220
dissection and acute aortic syndrome,
221
traumatic aortic injury, 221
Thoracic aortic aneurysm (TAA), 207
Thoracic endovascular repair (TEVR), 207
other equipment required for, 215
preoperative measurements required for,
210f, 210t
types of pathology treated by, 207
Thrombectomy for deep venous thrombosis,
see Venous thrombolysis and
thrombectomy for deep venous
thrombosis
Thrombolysis for acute lower limb ischemia
(ALLI)
clinical categories, angiographic patterns,
treatment(s), 280
complications and treatment, 278–279
contraindications for thrombolysis of
ALLI, 276–277
diagnostic evaluation of ALLI
clinical, 276
imaging, 276
laboratory, 276
indications for thrombolysis of ALLI, 276
introduction to ALLI, 275
irreversible/profound ischemia, 286
action, 287–288
angiographic findings, 287
clinical/physical findings, 286–287
doppler findings, 287
medications for ALLI, 278
patient preparation and monitoring for
thrombolytic infusion in ICU, 277
procedure, 277–278
threatened, 282–283
actions for threatened, 284–286
angiographic findings, 284
doppler findings, 284
viable, 280–281
action, 282
angiographic findings (examples),
281–282
clinical/physical findings, 281
doppler findings, 281
Thrombolysis in cerebral ischemia (TICI), 297t
Thrombolytics, 23
348 Index
TIPS, see Transjugular Intrahepatic
Portosystemic Shunts (TIPS)
Tolazoline, 24
Tools to perform angioplasty/stenting, 1
angiographic catheters, 3–4
angioplasty balloons, 6
modified balloons, 8
special purpose balloons, 6–8
essentials, 1t
guidewires, 4–6
sheaths and guide catheters, 2–3
treating lesion, 6
vascular stents and stent grafts
stent grafts, 11
stents, 8–11
Tortuous antecubital outflow vein, 267f
Trans-Atlantic Inter-Society Consensus
Document on Management of
Peripheral Arterial Disease (TASC),
91
Transient ischemic attacks (TIA), 170
Transjugular Intrahepatic Portosystemic
Shunts (TIPS)
complications, 333–334
concept and definition, 327
contraindications, 330
indications for tips, 330
material selection
materials, 331
procedure, 331–333
stents, 331
post-procedure management, 333
pre-procedure evaluation
clinical evaluation, 327
imaging and endoscopy, 328
laboratory, 328
procedure preparation, 330
prognostic models, 328
APACHE II, 329
child-pugh score, 328
meld score, 329
prognostic index, 329
results, 334–335
Traumatic aortic injury, 221
Tsetis, Dimitrios K., 27
U
Uberoi, Raman, 17
Ulcers, medical treatment of, 19
Urokinase, 23
V
Vascular access
principles of angioplasty/stenting, 60
stent-grafting of thoracic aorta,
complications, 222
Vascular closure devices (VCD)
angioseal, 77–78
benefits of, 82
drawbacks of, 82
passive, see Passive VCD
prostar XL10 and perclose A-T, 74–77
StarClose, 78
types of, 74
Vascular sheath, 2
Vascular stents and stent grafts
stent grafts, 11
stents, 8–11
Vasodilators, medications, 23–24
Vedantham, Suresh, 317
Venoplasty and stenting, 303
alternative therapies, 313–314
clinical feature, 303–304
complications, 314
contraindications, 307–308
diagnostic evaluation
clinical, 304–305
imaging, 305–307
laboratory, 305
equipment, 309
indications, 307
patient preparation, 308
pre-procedure medications, 309
procedure
assessing narrowing or occlusion,
310–311
choosing balloon or stent, 311
follow-up and post-procedure
medications, 313
intra-procedural medications, 310
performing the procedure, 311–313
venous access, 309–310
relevant anatomy
aberrant anatomy, 308
normal anatomy, 308
results, 313
Venous access, 41
equipment, 42–43
femoral vein, access into, 43
anatomy, 44
complications, 46
contraindications, 43
indications, 43
patient preparation, 43
performing the procedure, 44–45
Inferior Vena Cava (IVC), access into, 53
anatomy, 54
Index 349
complications, 55
contraindications, 54
patient preparation, 54
performing the procedure, 54
Internal Jugular Vein (IJV), access into, 47
anatomy, 48
complications, 51
contraindications, 48
indications, 47–48
patient preparation, 48
performing the procedure, 49–51
popliteal vein, access into
anatomy, 46–47
complications, 47
contraindications, 46
indications, 46
patient preparation, 46
performing the procedure, 47
principles, 41–42
subclavian vein, access into, 51
anatomy, 52
complications, 53
contraindications, 52
indications, 52
patient preparation, 52
performing the procedure, 52–53
ultrasound for, 42
venoplasty and stenting, 309–310
Venous anastomotic stenosis, 268f
left forearm graft with, 253f
Venous and arterial anastamoses, 257f
Venous stenosis, balloon angioplasty of, 62f
Venous thromboembolism (VTE), 317
Venous thrombolysis and thrombectomy for
deep venous thrombosis
anatomical considerations, 320–321
clinical features, 317–318
diagnostic evaluation
clinical, 319
imaging, 319
laboratory, 319
indications for endovascular DVT
thrombolysis, 319–320
patient preparation, 320
percutaneous options for acute DVT
catheter-directed pharmacological
thrombolysis (“infusion-first
CDT”), 322–323
pharmacomechanical catheter-directed
thrombolysis (PCDT), 324–325
stand-alone percutaneous mechanical
thrombectomy(PMT), 323–324
Vertebral artery, see Intracranial and vertebral
artery angioplasty/stenting
Vessel perforation, 126–127
W
Warfarin, management, 19–20
Wyse, Gerald, 167
Z
Zomorodi, Ali R., 291